Articles published by Scholar Rock

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 16, 2024

Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer

February 15, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management

February 06, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia

January 25, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity

January 23, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 12, 2024

From Scholar Rock

Via Business Wire

Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 19, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 15, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 17, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability

November 03, 2023

From Scholar Rock

Via Business Wire

Scholar Rock to Participate in Upcoming Investor Conferences

November 02, 2023

From Scholar Rock

Via Business Wire

Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023

October 23, 2023

From Scholar Rock

Via Business Wire

Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting

October 19, 2023

From Scholar Rock

Via Business Wire

Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders

October 11, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial

September 19, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 15, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 18, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress

August 09, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 13, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 15, 2023

From Scholar Rock

Via Business Wire

Scholar Rock to Present at the Jefferies Healthcare Conference

June 01, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 10, 2023

From Scholar Rock

Via Business Wire

Scholar Rock to Present New Data Evaluating Apitegromab at 36 Months from the Phase 2 TOPAZ trial at the 2023 Annual Cure SMA Conference

May 08, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 12, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors

April 10, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 15, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress

March 07, 2023

From Scholar Rock

Via Business Wire

Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

March 01, 2023

From Scholar Rock

Via Business Wire

Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference

February 27, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 17, 2023

From Scholar Rock

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Articles published by Scholar Rock